Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MECP2 | hg19_v2_chrX_-_153363188_153363212 | -0.14 | 4.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_2050852 Show fit | 4.20 |
ENST00000541165.1
ENST00000591601.1 |
MAP kinase interacting serine/threonine kinase 2 |
|
chr7_-_139477500 Show fit | 3.97 |
ENST00000406875.3
ENST00000428878.2 |
homeodomain interacting protein kinase 2 |
|
chr10_+_6186847 Show fit | 3.64 |
ENST00000536985.1
ENST00000379789.4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
chr19_+_35521616 Show fit | 3.24 |
ENST00000595652.1
|
sodium channel, voltage-gated, type I, beta subunit |
|
chr20_+_48807351 Show fit | 3.22 |
ENST00000303004.3
|
CCAAT/enhancer binding protein (C/EBP), beta |
|
chr9_+_137218362 Show fit | 3.14 |
ENST00000481739.1
|
retinoid X receptor, alpha |
|
chr19_-_33793430 Show fit | 3.02 |
ENST00000498907.2
|
CCAAT/enhancer binding protein (C/EBP), alpha |
|
chr9_-_134615326 Show fit | 2.97 |
ENST00000438647.1
|
Rap guanine nucleotide exchange factor (GEF) 1 |
|
chr16_+_21610879 Show fit | 2.91 |
ENST00000396014.4
|
methyltransferase like 9 |
|
chr20_+_57466461 Show fit | 2.82 |
ENST00000306090.10
|
GNAS complex locus |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 73.8 | GO:0042119 | neutrophil activation(GO:0042119) |
0.3 | 39.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 21.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 16.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.4 | 14.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 14.5 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.2 | 14.4 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.2 | 11.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 10.6 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 10.0 | GO:0006413 | translational initiation(GO:0006413) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 100.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 87.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 57.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 42.6 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 36.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 35.0 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.3 | 31.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 30.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 29.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 27.4 | GO:0035579 | specific granule membrane(GO:0035579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 49.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 31.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 29.3 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 19.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 17.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 15.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 14.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 14.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.6 | 13.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 13.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 28.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 25.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 21.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 19.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 19.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 19.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 16.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 16.7 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 16.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 13.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 54.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 21.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 19.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 19.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 18.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 17.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 16.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 16.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 14.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 14.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |